KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Non-Current Debt: 2009-2025

Historic Non-Current Debt for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to $2.4 billion.

  • Encompass Health's Non-Current Debt rose 210.71% to $2.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 210.71%. This contributed to the annual value of $2.4 billion for FY2024, which is 1222.56% down from last year.
  • Encompass Health's Non-Current Debt amounted to $2.4 billion in Q3 2025, which was up 210.71% from $2.3 billion recorded in Q2 2025.
  • Encompass Health's Non-Current Debt's 5-year high stood at $3.2 billion during Q4 2021, with a 5-year trough of $2.3 billion in Q2 2025.
  • For the 5-year period, Encompass Health's Non-Current Debt averaged around $2.8 billion, with its median value being $2.7 billion (2023).
  • As far as peak fluctuations go, Encompass Health's Non-Current Debt soared by 411.5% in 2022, and later plummeted by 1657.34% in 2023.
  • Over the past 5 years, Encompass Health's Non-Current Debt (Quarter) stood at $3.2 billion in 2021, then decreased by 15.39% to $2.7 billion in 2022, then decreased by 1.97% to $2.7 billion in 2023, then dropped by 12.23% to $2.4 billion in 2024, then rose by 1.47% to $2.4 billion in 2025.
  • Its last three reported values are $2.4 billion in Q3 2025, $2.3 billion for Q2 2025, and $2.3 billion during Q1 2025.